A Federal Register scheduling notice is a structured document, and once you know the structure you can answer the three questions that actually matter — what is covered, at what amount, and from when — in about five minutes. Almost all the confusion circulating about the 2026 kratom action comes from people reading a headline or a summary instead of the four blocks that carry the legal content.
This post teaches the skill using the two notices published on July 6, 2026 as worked examples. The method transfers to any scheduling document you encounter later.
Quick Answer: The Anatomy of the Document
| Block | What it tells you |
|---|---|
| Header (Agency, CFR part, Docket No.) | Who is acting, which regulation is being amended, and the internal file number |
| ACTION line | What kind of document this is. The single most useful line on the page. |
| SUMMARY | The scope in one paragraph, including the isomer and salt language |
| DATES | Effective dates and comment deadlines. Routinely misread. |
| SUPPLEMENTARY INFORMATION | The reasoning, the thresholds, the statutory authority and the findings |
Start With the ACTION Line
Both of the July 2026 documents carry the ACTION line "Proposed amendment; notice of intent." That tells you immediately that neither document controls anything yet. A notice of intent announces what the agency plans to do and starts a statutory clock. It is not the order.
Four document types show up in this area, and confusing them is the most common error:
- Notice of intent — announces a forthcoming temporary scheduling order and starts the 30-day clock. No immediate legal effect on products.
- Temporary scheduling order — the operative document. Effective on the date it publishes. Contains the registration requirement and the disposal-of-stocks provisions.
- Proposed rule — the first step of permanent scheduling, with a comment period.
- Final rule — completes permanent scheduling, usually with a stated effective date some weeks out.
If someone tells you a substance "was banned on July 6," check the ACTION line of what they are citing. It was not.
Document Numbers, Docket Numbers and Citations
Three different identifiers appear on these pages and they are not interchangeable.
The FR document number has the form YYYY-NNNNN and is assigned by the Office of the Federal Register at publication. Our two are 2026-13580 and 2026-13581. This is the stable retrieval key; appending it to federalregister.gov/d/ pulls up the original.
The docket number is the agency's own file identifier and is unrelated to the FR number. The 7-OH notice carries Docket No. DEA-1570; the notice covering the three related substances carries Docket No. DEA-1644. Different dockets mean these are two genuinely separate proceedings that happen to have published on the same day.
The volume and page citation, written as a volume number, "FR", and a starting page, is what you use in formal writing. Every notice also names the CFR part it would amend — here, 21 CFR Part 1308, which is where the federal drug schedules live.
The practical habit: always retrieve by document number and read the original. Do not rely on a summary, including this one. Our companion piece on whether 7-OH is banned works through the same documents in narrative form.
Read the DATES Block Twice
This is where most misreadings happen, because scheduling documents use date language that looks like other rulemaking but behaves differently.
Under 21 U.S.C. 811(h)(1), a temporary scheduling order may not be issued before 30 days have passed from publication of the notice. The notices published July 6, 2026, which produces the "on or after August 5, 2026" figure everyone is quoting. Three things follow that people get wrong:
- "On or after" is not "on." August 5 is the earliest possible date, not a scheduled one. The order may publish later, and nobody outside the agency knows which day.
- The 30 days is a constraint on the agency, not a grace period for you. It runs before the order exists and is over the moment the order publishes.
- The order takes effect on the date it publishes. The notice says so explicitly. There is no interval between publication and effect, which is different from most federal rules and is the source of the widespread and incorrect belief in a sell-through window. We cover the consequences in what happens to inventory after a ban.
Also distinguish an effective date from a comment deadline. Comment periods appear in the ADDRESSES block and have nothing to do with when a rule bites.
Thresholds: Read the Units, and Read the Conjunctions
A threshold-based schedule is unusual, and the 7-OH notice contains one of the more intricate examples in recent memory. It defines coverage in two parts.
Part (A) covers botanical material of Mitragyna speciosa containing more than 0.050 percent 7-OH on a dry weight basis.
Part (B) covers alternative articles: material resulting from synthetic methods containing 7-OH greater than 0.050 percent by weight/weight, weight/volume or volume/volume, or greater than 1.00 milligram of 7-OH in the article; and material derived from the plant and further processed into extracts, concentrates, processed edibles or pressed pills above the same 0.050 percent figure.
Three reading habits matter here:
- The conjunction is "or," not "and." A product can be covered by exceeding the concentration figure or by exceeding the per-article milligram figure. Either one alone is sufficient. A dilute product in a large serving can trip the per-article limit while sitting well under the percentage.
- Weight-for-weight, weight-for-volume and volume-for-volume are different measurements. A liquid quoted in one basis cannot be casually compared to a tablet quoted in another.
- "In the article" requires knowing what the article is. A tablet, a sachet, a shot bottle, a whole multi-pack — the answer changes the arithmetic by an order of magnitude. If a certificate reports a per-gram figure and the product is a 30-gram bottle, you have work to do. Our explainer on the 7-OH threshold works through this in detail.
Now compare the second notice, and notice what is absent. It covers mitragynine pseudoindoxyl, MGM-15 and MGM-16 with no threshold whatsoever. Any detectable quantity is covered. That single structural difference changes the analytical question completely: for 7-OH you need a quantitative result to compare against a number, while for the other three you need a panel that looks for them at all. A certificate that reports non-detect for 7-OH says nothing about compounds that were never on the method. That distinction is the subject of what non-detect actually means, and it is the reason we describe our own certificates the way we do.
The Isomers, Esters, Ethers and Salts Language
Both notices carry a phrase that looks like boilerplate and is anything but. The scope includes the named substance "including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible."
This is standard Controlled Substances Act drafting, and its function is to extend coverage to chemical relatives of the named molecule without any further rulemaking. In plain terms: a compound that does not appear by name in the notice can still be covered if it is a salt or an isomer of something that does. Reading only the named-substance list understates the scope, sometimes considerably.
Read the "handle" definition in the SUMMARY with the same care. These notices define handling as manufacture, distribution, reverse distribution, import, export, research, instructional activities, chemical analysis, or simple possession. That list is what determines who the order reaches, and it reaches almost everyone in a supply chain. For the compounds themselves, see MGM-15 and MGM-16 explained.
The Authority Citation Tells You the Rules of the Game
Look for the statutory citation early in the SUPPLEMENTARY INFORMATION. There are two very different pathways.
21 U.S.C. 811(a) is permanent scheduling. It requires a full eight-factor analysis, an HHS scientific and medical evaluation, notice and comment, and it produces a rule subject to judicial review.
21 U.S.C. 811(h) is temporary scheduling, and both July 2026 notices proceed under it. The differences are substantial. The Administrator must consider only three of the eight factors — history and current pattern of abuse; scope, duration and significance of abuse; and risk to public health — and must find that placement is necessary to avoid an imminent hazard to public safety. Placement can only be into Schedule I. It lasts two years, extendable by one while permanent scheduling is considered. And under 811(h)(6) the resulting order is not subject to judicial review, which removes the litigation route businesses normally reach for.
The Two Notices Side by Side
| FR Doc 2026-13580 | FR Doc 2026-13581 | |
|---|---|---|
| Docket | DEA-1570 | DEA-1644 |
| Substances | 7-hydroxymitragynine above a specified threshold | Mitragynine pseudoindoxyl, MGM-15, MGM-16 |
| Threshold | 0.050% on a weight basis, or 1.00 mg per article | None. Any detectable amount. |
| Authority | 21 U.S.C. 811(h) | 21 U.S.C. 811(h) |
| Published | July 6, 2026 | July 6, 2026 |
| Earliest effect | On or after August 5, 2026 | On or after August 5, 2026 |
Five Common Misreadings
- Treating the notice of intent as the ban itself.
- Reading "on or after August 5" as a fixed date.
- Reading the 30-day statutory waiting period as an inventory grace period.
- Assuming both notices carry a threshold. Only one does.
- Ignoring the isomers and salts language, and therefore underestimating scope.
A sixth worth adding: federal scheduling does not preempt state law, and state schedules move on their own timetable. See state kratom and 7-OH laws in 2026.
Where to Find the Primary Document
Go to federalregister.gov and search the document number. Read the regulatory text at the end rather than the summary at the top, because the summary is written for readability and the regulatory text is what has legal effect. Where a comment docket exists, it will be identified in the ADDRESSES block.
We read these ourselves rather than relying on trade-press summaries, and we recommend the same to anyone with inventory or money at stake. We are a distributor and retailer of third-party brands — we do not manufacture or formulate anything — so our job is to screen what we stock and document it honestly. The certificates for what we carry are on our COA page, and they report non-detect for 7-OH, mitragynine and several related leaf alkaloids. They do not test for mitragynine pseudoindoxyl, MGM-15, MGM-16 or corynoxine B, and we do not claim they do.
Frequently Asked Questions
Is a Notice of Intent the same as a ban?
No. It announces a forthcoming temporary scheduling order and starts a 30-day clock. The order that follows is the document with legal effect, and it takes effect on the date it publishes.
What does "above a specified threshold" mean in practice?
It means coverage depends on measurement rather than on the name of the plant. For the 7-OH notice the figures are more than 0.050 percent on a weight basis or more than 1.00 milligram in the article, and either one alone is enough.
Why do the two notices have different structures?
They address different substances. 7-OH occurs naturally in kratom leaf at low levels, so a threshold distinguishes ordinary leaf material from concentrates. Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are not treated that way in the second notice, which covers any detectable amount.
Can a temporary scheduling order be challenged in court?
Under 21 U.S.C. 811(h)(6), an order issued under that authority is not subject to judicial review. That is unusual and it is stated directly in the notice.
How long does temporary scheduling last?
Two years from the effective date, with a possible extension of up to one additional year while permanent scheduling under 811(a) is considered.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. For adults 21+. Legality depends on the specific formulation and applicable state law — check the rules where you live. Nothing here is legal advice.